HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

OTC Labeling Reg Inapplicable To Professional-Use Kits - Becton Dickinson

This article was originally published in The Tan Sheet

Executive Summary

FDA's OTC labeling rules should not apply to blood culture "convenience" kits containing OTC drug components used by health care professionals, Becton, Dickinson & Co. asserts.

You may also be interested in...



Bactec Kit Outer Labeling Only Required To Comply With “Drug Facts” Format

The individual OTC components in Becton Dickinson's Bactec Blood Culture Procedural Tray will not be required to carry "Drug Facts" labeling as long as the kit's outer package uses the OTC labeling format to describe the components, FDA says in a June 5 letter to the firm

Thursday Plantation

Australia-based tea tree manufacturer requests exemption from OTC labeling final rule for 2 oz. 100% Pure Tea Tree Oil, saying compliance is "impracticable" because "label size is too small to fit bar lines and all the wording in the font size required." Moreover, "should the font size be decreased, the letters bleed slightly, which may cause deterioration of text legibility," company maintains in March 23 letter to FDA. Antiseptic is sold in health food stores worldwide under Thursday Plantation brand

OTC Labeling Exemption, Deferral Timelines Depend On Complexity - FDA

FDA expects to respond to completed OTC labeling exemption and deferral requests that are straightforward or "consistent with previously granted requests" in 30 to 60 days, the agency says.

Topics

UsernamePublicRestriction

Register

RS132492

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel